Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MENVEO DIN 02563029

Status: Marketed
Holder: GLAXOSMITHKLINE INC
Molecule: MENINGOCOCCAL GROUP A OLIGOSACCHARIDE

Health Canada record

Active ingredient(s)MENINGOCOCCAL GROUP A OLIGOSACCHARIDE 10 MCG; MENINGOCOCCAL GROUP C OLIGOSACCHARIDE 5 MCG; MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE 5 MCG; MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE 5 MCG
Dosage formSolution
RouteIntramuscular
ScheduleSCHEDULE D
ClassHuman
ATCJ07AH08 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN CONJUGATED
Original market date13-Apr-2026
Current status date13-Apr-2026
SourceHealth Canada DPD

Establishment licence of the holder

GlaxoSmithKline Inc. — licence 100630, currently licensed, last inspection rating C (2025-09-15).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing MENINGOCOCCAL GROUP A OLIGOSACCHARIDE

DINProductCompanyFormStrengthStatus
02347393MENVEOGLAXOSMITHKLINE INCPowder For Solution; SolutionMENINGOCOCCAL GROUP A OLIGOSACCHARIDE 10 MCG; MENINGOCOCCAL GROUP C OLIGOSACCHARIDE 5 MCG; MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE 5 MCG; MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE 5 MCG; CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN 47 MCGMarketed

Notices of Compliance

NOCDateSubmissionReason
365452025-11-21Supplement to a New Drug Submission (SNDS)Addition of a new dosage form
Request a quote for MENVEO

How to read a Canadian DIN record